Abstract

Sustainability, affordability, and equity of corporate drug donations: the case of Malarone

Shretta R, Brugha R, Robb A, Snow RW
Lancet. 2000;355

Permenent descriptor
https://doi.org/10.1016/S0140-6736(00)02251-0


No abstract available

Publication metrics
Dimensions Badge

Altmetric

Key Terms
Antimalarials/ economics | Atovaquone | Charities/ economics | Developing Countries | Drug Combinations | Drug Industry/ economics | Humans | Kenya | Naphthoquinones/ economics | Proguanil/ economics (Source: Medline)
External Sources
Abstract at pubmed
Full text at publishers website